| Dr Stephen Howard Montaldi, DO | |
|
1007 N 16th St, New Castle, IN 47362-4319 | |
| (765) 529-0780 | |
| (765) 529-3554 |
| Full Name | Dr Stephen Howard Montaldi |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Sports Medicine |
| Location | 1007 N 16th St, New Castle, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255446399 | NPI | - | NPPES |
| 200926520 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RS0010X | Internal Medicine - Sports Medicine | OS7171 (Florida) | Secondary |
| 207RS0010X | Internal Medicine - Sports Medicine | 002003452 (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stephen Howard Montaldi, DO Po Box 530, 1007 N 16th St, New Castle, IN 47362-4319 Ph: (765) 529-0780 | Dr Stephen Howard Montaldi, DO 1007 N 16th St, New Castle, IN 47362-4319 Ph: (765) 529-0780 |
News Archive
A key immune signal has a previously unknown role in turning off the immune system's attack on pancreatic cancer cells, a new study finds.
Researchers have discovered the second, strong genetic risk factor for developing late-onset Alzheimer's disease, according to a new report in the June 27th issue of the journal Cell, a Cell Press publication.
DiFusion Incorporated announced today that the company has received a CE Mark and European clearance to market and implant its new CleanFuze antimicrobial orthobiologic polymer. "We are extremely gratified to announce European clearance of our CleanFuze line of antimicrobial spinal implants. This material has been in development for over five years and attaining this milestone represents significant value for our shareholders," commented DiFusion Cofounder and CEO Derrick Johns.
The immunotherapy drug nivolumab has become the first to show a survival benefit in head and neck cancer, after a major international trial found that it was more effective than standard chemotherapy.
A Mayo Clinic research team has challenged the accepted theory on the cause of sepsis - a condition in which the body's cells generate fever, shock and often death. Sepsis is thought to occur when poisons from bacterial infection interfere with the cells.
› Verified 7 days ago
Jordan E Dicken, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 N 16th St Ste 240, New Castle, IN 47362 Phone: 765-521-1461 Fax: 765-599-3101 | |
Steven E. Miller, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 152 Wittenbraker Ave, New Castle, IN 47362 Phone: 765-599-3100 Fax: 765-518-5365 | |
Dr. John Lawrence Davisson, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 N 16th St, New Castle, IN 47362 Phone: 765-521-0890 Fax: 765-521-1555 | |
Arun K. Tewari, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 N 16th St, New Castle, IN 47362 Phone: 765-521-0890 Fax: 765-521-1555 | |
Dr. Romana N Malik, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2200 Forest Ridge Pkwy Ste 310, New Castle, IN 47362 Phone: 765-599-3400 Fax: 765-599-3426 | |
Charles Stanley Marting, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 N 16th St, New Castle, IN 47362 Phone: 765-599-3177 Fax: 765-599-3176 |